Skip to content

Clinical trials

Phase 3 Prostatic Neoplasms trials in Finland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Phase: Phase 3 Country / region: Finland Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20052
20061
20072
20084
20094
20104
20112
20121
20133
20142
20151
20161
20171
20191
20203
20211
20221
20231
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Active, not recruiting5
Recruiting5
Terminated4
Unknown status3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca6
Pfizer6
Ferring Pharmaceuticals5
Bayer2
Blue Earth Diagnostics2
Millennium Pharmaceuticals, Inc.2
Sanofi2
Tampere University Hospital2
Amgen1
Aragon Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms41
Neoplasms3
Carcinoma2
Disease2
Breast Neoplasms1
Bulbo-Spinal Atrophy, X-Linked1
Carcinoma, Renal Cell1
Genital Diseases, Male1
Genital Neoplasms, Male1
Kidney Neoplasms1

Trials

Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.